Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoetin (ausschließlich Epoetin zeta), ATC B03XA01 für die Zeit 01.12.2024 - 30.11.2026
Original language: German
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- Pfizer Pharma GmbH, Stadapharm GmbH
- Contract value
- no value published
- Bids received
- 8
- Published
- 2 Jul 2026
- Awarded
- 1 Dec 2024
- Contract start
- 1 Dec 2024
- Contract end
- 14 Dec 2025estimated
- Region
- Hamburg